Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 1/20 | 0.36 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.36 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.36 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.36 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.34 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 6/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30921698 | 1.00 | PI4KA (0.36) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL25821882 | 0.89 | PI4KA (0.36) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL25825362 | 0.89 | PI4KA (0.36) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL24606276 | 0.86 | PIK3CD (0.31) | TMPRSS2PIK3CD | |
| SCHEMBL23959859 | 0.83 | TMPRSS2 (0.47) | TMPRSS2ACVRL1PIK3CD | |
| SCHEMBL30418526 | 0.83 | TMPRSS2 (0.44) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL12393281 | 0.83 | TMPRSS2 (0.44) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL22142989 | 0.83 | TMPRSS2 (0.44) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL26319768 | 0.83 | TMPRSS2 (0.44) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 | |
| SCHEMBL26326095 | 0.83 | TMPRSS2 (0.44) | PI4KAPI4K2BPI4K2API4KBTMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4617278-A1 | NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF | Shenzhen TargetRx, Inc. (CN) | 2025-09-17 | — | — | EP | disclosed |
| WO-2024120464-A1 | NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF | 深圳市塔吉瑞生物医药有限公司 | 2024-06-13 | — | — | WO | disclosed |